Large-scale Mendelian randomization identifies novel pathways as therapeutic targets for heart failure with reduced ejection fraction and with preserved ejection fraction

Rasooly D, Giambartolomei C, Peloso GM, Dashti H, Ferolito BR, Golden DJ, Horimoto ARVR, Pietzner M, Farber-Eger EH, Wells QS, Bini G, Proietti G, Tartaglia GG, Kosik NM, Wilson PWF, Phillips LS, Munroe PB, Petersen SE, Cho K, Gaziano JM, Leach AR, VA Million Veteran Program, Whittaker J, Langenberg C, Aung N, Sun YV, Pereira AC, Joseph J, Casas JP.
medRxiv 2024.03.22.24304728; doi: https://doi.org/10.1101/2024.03.22.24304728
Preprint
Mar 22, 2024